We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Respiratory Effects of Algal Toxins

By Biotechdaily staff writers
Posted on 01 Dec 2004
Researchers seeking new drugs to treat the mucus build-up associated with cystic fibrosis and similar lung diseases have isolated a compound from the red tide alga Karenia brevis that has a powerful positive effect on the flow of mucus through the respiratory tract.

The red tide toxic algal blooms are caused by several genera of dinoflagellates, which turn the sea red and are frequently associated with deterioration in water quality. More...
The color occurs as a result of the reaction of a red pigment, peridinin, to light during photosynthesis. These toxic algal blooms pose a serious threat to marine life and are potentially harmful to humans. In particular, particles containing toxins become aerosolized by the action of wind and waves and cause irritation of the eyes, nose, throat, lips, and tongue.

Investigators at Mount Sinai Medical Center (Miami, FL, USA) and University of North Carolina's Center for Marine Science (Wilmington, USA) studied compounds produced by K brevis in order to identify those affecting the respiratory tract. They found three active toxins and one compound, brevenal, which was shown to have a beneficial effect on the respiratory tract. Additionally, a synthetic compound, beta-naphthoyl-brevetoxin, was produced that worked in a similar fashion to brevenal.

"We found these compounds are able to speed up the clearance of mucus from the lungs,” said senior author Dr. Daniel Baden, director of the University of North Carolina's Center for Marine Science. "These compounds will serve as experimental models in the development of drug therapies for those who suffer from cystic fibrosis and other lung disorders characterized by excessive mucus secretion.”

These findings were published in the September 24, 2004, online edition of the American Journal of Respiratory and Critical Care Medicine.

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.